---
layout: post
title: "Prescription Drug User Fee Rates for Fiscal Year 2023"
date: 2026-02-05 19:01:02 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-21968
original_published: 2022-10-07 00:00:00 +0000
significance: 8.00
---

# Prescription Drug User Fee Rates for Fiscal Year 2023

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 07, 2022 00:00 UTC
**Document Number:** 2022-21968

## Summary

The Food and Drug Administration (FDA) is announcing the rates for prescription drug user fees for fiscal year (FY) 2023. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2022 (PDUFA VII), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2023. These fees apply to the period from October 1, 2022, through September 30, 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/07/2022-21968/prescription-drug-user-fee-rates-for-fiscal-year-2023)
- API: https://www.federalregister.gov/api/v1/documents/2022-21968

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
